PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.\', \'COVID-19 Unit, Azienda Policlinico \'Umberto I\' University Hospital, Rome, Italy.\', \'Medical Statistic and Molecular Epidemiology Unit, University of Biomedical Campus, Rome, Italy.\', \'Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.\', \'Laboratório de Genética Celular e Molecular, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.\', \'Unit of Clinical Laboratory Science, University of Biomedical Campus, Rome, Italy.\', \'Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy, giancarlo.ceccarelli@uniroma1.it.\', \'COVID-19 Unit, Azienda Policlinico \'Umberto I\' University Hospital, Rome, Italy, giancarlo.ceccarelli@uniroma1.it.\', \'Migrant and Global Health Research Organization (Mi-HeRo), Rome, Italy, giancarlo.ceccarelli@uniroma1.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1159/000515344
?:hasPublicationType
?:journal
  • Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33756475
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.524
?:rankingScore_hIndex
  • 47
?:title
  • Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all